[Tumor suppressors--genes and proteins]

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Context:

• Cancer is fundamentally a genetic disease, initiated and driven by somatic mutations.
• Over the past two decades, significant advancements have been made in understanding cancer-associated genes and their products.
• Tumor suppressor genes (TSGs) play a critical role in preventing uncontrolled cell growth and inducing programmed cell death (apoptosis).

Purpose:

• To elucidate the role of tumor suppressor genes (TSGs) in cancer initiation and development.
• To highlight the significance of TSGs, including TP53, RB1, and CDKN2A, in cell cycle regulation.
• To underscore the implications of TSG mutations in hereditary cancer syndromes and sporadic tumors.

Summary:

• TSGs encode proteins that regulate cell growth and apoptosis; their biallelic inactivation is a hallmark of cancer cells.
• Mutations in TSGs, like the frequently altered TP53 gene, disrupt normal cellular functions, increasing cancer risk.
• The study of TSGs has identified key molecular genetic markers for cancer diagnosis and prognosis.

Impact:

• Characterization of TSGs has led to new diagnostic and prognostic tools in oncology.
• TSGs represent promising therapeutic targets for gene therapy in cancer and other hyperproliferative disorders.
• Understanding TSG function is vital for developing targeted cancer treatments and preventative strategies.